chr19-20105235-A-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_007138.2(ZNF90):c.145A>G(p.Lys49Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000304 in 1,602,494 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_007138.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF90 | ENST00000418063.3 | c.145A>G | p.Lys49Glu | missense_variant | Exon 3 of 4 | 1 | NM_007138.2 | ENSP00000410466.2 | ||
ZNF90 | ENST00000469078.5 | n.145A>G | non_coding_transcript_exon_variant | Exon 3 of 6 | 5 | ENSP00000420111.1 | ||||
ZNF90 | ENST00000473524.5 | n.145A>G | non_coding_transcript_exon_variant | Exon 3 of 5 | 3 | ENSP00000418166.1 | ||||
ZNF90 | ENST00000474284.1 | n.157A>G | non_coding_transcript_exon_variant | Exon 2 of 4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152226Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000220 AC: 54AN: 245522 AF XY: 0.000233 show subpopulations
GnomAD4 exome AF: 0.000313 AC: 454AN: 1450150Hom.: 1 Cov.: 30 AF XY: 0.000315 AC XY: 227AN XY: 721422 show subpopulations
GnomAD4 genome AF: 0.000217 AC: 33AN: 152344Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74492 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.145A>G (p.K49E) alteration is located in exon 3 (coding exon 3) of the ZNF90 gene. This alteration results from a A to G substitution at nucleotide position 145, causing the lysine (K) at amino acid position 49 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at